Drugs / Tibetree Pain Relieving Plaster
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04916249 | May 2021 → May 2027 expected | cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tibetree Pain-Relieving Plaster | “We will instruct the participants to apply the herbal patch (Tibetree Pain-Relieving Plaster, Tibet Cheezheng Tibetan Medicine Co. Ltd., Tibet, China) or placebo patch daily at...” PMID 35600872 ↗ May 2022 |
| Route | Topical | “Participants will be instructed to apply the plaster directly to the skin overlying the area of pain” NCT04916249 ↗ |